| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/01/2008 | US7314887 Thrombopoietin activity modulating compounds and methods |
| 01/01/2008 | US7314886 Tetrahydropyrano-indole derivatives |
| 01/01/2008 | US7314885 (4-(4-(2,3-difluorophenyl)-4H-1,2,4-triazol-3-yl)-1H-pyrrol-2-yl)(2H-pyrrol-1(5H)-yl)methanone; anticarcinogenic, antiproliferative and antimetastasis agent; inhibitors of c-Met protein kinase |
| 01/01/2008 | US7314884 non-insulin dependent diabetes mellitus, and impaired glucose tolerance; dipeptidyl peptidase IV (DPP-IV) inhibitors eg (2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile |
| 01/01/2008 | US7314883 (+-)-3-(1H-Indazol-5-yl)-2-{[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carbonyl]-amino}-propionic acid to treat neurogenic vasodilation, neurogenic inflammaton, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases |
| 01/01/2008 | US7314882 Benzyl 2-oxo-6-phenyl-1,2,3,4-tetrahydro-1,5-naphthyridin-3-ylcarbamate; CB-1 antagonist; regulating appetitive behavior |
| 01/01/2008 | US7314881 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds |
| 01/01/2008 | US7314880 Cardioprotective delta opioid receptor agonists and methods of using same |
| 01/01/2008 | US7314879 N-Acylpiperazine derivatives for obesity, diabetes, and erectile dysfunction treatment; sexual disorders |
| 01/01/2008 | US7314878 Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or CNS disorders |
| 01/01/2008 | US7314877 Benzofuran derivative |
| 01/01/2008 | US7314876 Administering to mammals nitrogen compounds, as mitogen activated kinase inhibitors, for prophylaxis asthma, respiratory system disorders, graft versus host disease, atherosclerosis and arthritis |
| 01/01/2008 | US7314875 Tricyclic aromatic and bis-phenyl sulfinyl derivatives |
| 01/01/2008 | US7314874 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide;modified amidine elements of high potency in vitro, excellent pharmacological and pharmaceutical properties in vivo |
| 01/01/2008 | US7314873 (Halo-benzo carbonyl)heterobi cyclic p38 linase inhibiting agents |
| 01/01/2008 | US7314872 Selective in presence of at least one other cathepsin isozyme; such as morpholine-4-carboxylic acid {2-cyclopentyl-1--[2-(4-methoxy-phenylamino)-1--methyl-ethylcarbamoyl]-ethyl}-amide |
| 01/01/2008 | US7314871 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors, for treatment of hypertension |
| 01/01/2008 | US7314870 Compounds, their preparation and use |
| 01/01/2008 | US7314869 Vaccine vector comprising isolated nucleic acid molecule which encodes sequence 2 linked to promoter |
| 01/01/2008 | US7314868 fusing cells; nucleic acid vector comprises a nucleotide sequence encoding a measles virus F glycoprotein and a nucleotide sequence encoding a chimeric measles virus H glycoprotein; nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface |
| 01/01/2008 | US7314862 Antitumor agent |
| 01/01/2008 | US7314860 Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions |
| 01/01/2008 | US7314742 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility |
| 01/01/2008 | US7314643 Soft capsule preparation |
| 01/01/2008 | US7314642 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants |
| 01/01/2008 | US7314640 Formulation and process for drug loaded cores |
| 01/01/2008 | US7314638 Preparing method for controlled released type tablet tamsulosin HCL and the tablet thereof |
| 01/01/2008 | US7314634 Use of polyphenols to treat skin conditions |
| 01/01/2008 | US7314633 Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof |
| 01/01/2008 | US7314627 Cationic lipid-mediated enhancement of nucleic acid immunization of cats |
| 01/01/2008 | US7314618 Novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR). The invention further relates to methods of diagnosis of |
| 01/01/2008 | US7314617 Platelet rich plasma, no exogenous activator; sodium bicarbonate buffer, citrate dextrose anticoagulant |
| 01/01/2008 | US7314612 Cosmetic compositions containing at least one heteropolymer and at least one gelling agent and methods of using the same |
| 01/01/2008 | US7314484 Methods and devices for treating aneurysms |
| 12/30/2007 | CA2593613A1 Novel naphthalene derivatives, process for their preparation and pharmaceutical compositions containing them |
| 12/30/2007 | CA2592727A1 Nanoparticulate and controlled release compositions comprising a cephalosporin |
| 12/30/2007 | CA2558160A1 Antisense oligonucleotides for treatment of muscle wasting |
| 12/27/2007 | WO2007150075A2 Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone |
| 12/27/2007 | WO2007150074A2 Compositions comprising nanoparticulate naproxen and controlled release hydrocodone |
| 12/27/2007 | WO2007150064A2 METHOD FOR THE TREATMENT OF NEUROLOGICAL DISORDERS BY ENHANCING THE ACTIVITY OF β-GLUCOCEREBROSIDASE |
| 12/27/2007 | WO2007150063A2 Compositions for lowering blood serum cholesterol and use in foods, beverages, and health supplements |
| 12/27/2007 | WO2007150026A2 Purinone derivatives as hm74a agonists |
| 12/27/2007 | WO2007150018A2 Steroid-containing sustained release intraocular implants and related methods |
| 12/27/2007 | WO2007150016A2 Il-8 receptor antagonist |
| 12/27/2007 | WO2007150015A2 Method of treatment |
| 12/27/2007 | WO2007150011A2 Prolyl hydroxylase inhibitors |
| 12/27/2007 | WO2007150010A2 Cyclopropyl amine derivatives as histamin h3 receptor modulators |
| 12/27/2007 | WO2007150002A2 PRODRUGS OF 5-AMINO-3-(3'-DEOXY-β-D-RIBOFURANOSYL)-THIAZOLO[4,5-d] PYRIMIDIN-2,7-DIONE |
| 12/27/2007 | WO2007150001A1 Pyrro[1,2-b]pyridazinone compounds |
| 12/27/2007 | WO2007149935A2 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator |
| 12/27/2007 | WO2007149929A1 Piperidine derivatives for the treatment of gastrointestinal and cns disorders |
| 12/27/2007 | WO2007149907A2 Pyrazoloquinazolinones as parp inhibitors |
| 12/27/2007 | WO2007149891A2 Crystalline forms of gemcitabine amide prodrug, compositions and use thereof |
| 12/27/2007 | WO2007149874A1 Imidazolidinone kv1.5 potassium channel inhibitors |
| 12/27/2007 | WO2007149865A2 Methods and compositions related to inhibition of ceramide synthesis |
| 12/27/2007 | WO2007149816A2 Strontium compositions and methods of treating osteoporotic conditions |
| 12/27/2007 | WO2007149815A1 Strontium compositions and methods of treating arthritic and or osteoporitic conditions |
| 12/27/2007 | WO2007149797A2 Use of organic compounds |
| 12/27/2007 | WO2007149782A2 Selective inhibitors for transferases |
| 12/27/2007 | WO2007149568A2 N- (4-chl0r0-3-methyl-5-is0xaz0lyl) -2- [2-methyl-4, 5- (methylenedioxy) phenylacetyl] -thiophene-3-sulfonamide |
| 12/27/2007 | WO2007149557A1 FUSED [d]PYRIDAZIN-7-ONES |
| 12/27/2007 | WO2007149529A2 Thrombopoietic compounds |
| 12/27/2007 | WO2007149512A2 Peptide epoxyketones for pr0teas0me inhibition |
| 12/27/2007 | WO2007149508A2 Non-competitive nmda receptor antagonists |
| 12/27/2007 | WO2007149500A2 Formulations containing hybrid dendrimers |
| 12/27/2007 | WO2007149456A2 Methods and compositions for diagnostic and therapeutic targeting of cox-2 |
| 12/27/2007 | WO2007149451A2 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 12/27/2007 | WO2007149448A2 Pyrazinones as cellular proliferation inhibitors |
| 12/27/2007 | WO2007149427A2 Tyrosine kinase inhibitors |
| 12/27/2007 | WO2007149395A2 2,5-substituted oxazole derivatives as protein kinase inhibitors for the treatment of cancer |
| 12/27/2007 | WO2007149392A1 Mono quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors |
| 12/27/2007 | WO2007149382A2 Therapeutic compositions and methods useful in treating hepatitis |
| 12/27/2007 | WO2007149366A1 Prolonged improvement of renal function comprising infrequent administration of an aa1ra |
| 12/27/2007 | WO2007149313A1 Metformin r-(+) lipoate as an antidiabetic agent for control of diabetic hyperglycemia and diabetic complications |
| 12/27/2007 | WO2007149285A2 Method of improved diuresis in individuals with impaired renal function |
| 12/27/2007 | WO2007149272A1 Formulation for hair growth |
| 12/27/2007 | WO2007149211A1 Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity |
| 12/27/2007 | WO2007149163A2 Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors |
| 12/27/2007 | WO2007149119A1 Water stabilized aerosol formulation system and method of making |
| 12/27/2007 | WO2007149033A1 Substituted isoindoles as bace inhibitors and their use |
| 12/27/2007 | WO2007149031A1 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases |
| 12/27/2007 | WO2007149030A1 Novel heteroaryl substituted benzoxazoles |
| 12/27/2007 | WO2007148950A1 Synergistic pharmaceutical composition of ketorolac and lysine clonixinate |
| 12/27/2007 | WO2007148837A1 Composition capable of promoting the production of collagen |
| 12/27/2007 | WO2007148835A1 Agent for overcoming resistance to anti-cancer agent |
| 12/27/2007 | WO2007148808A1 Tricyclic compound and pharmaceutical use thereof |
| 12/27/2007 | WO2007148806A1 Methods of using a thiazole derivative |
| 12/27/2007 | WO2007148804A1 Composition capable of promoting the production of hyaluronic acid |
| 12/27/2007 | WO2007148803A1 Composition capable of promoting the production of hyaluronic acid |
| 12/27/2007 | WO2007148798A1 Reduced coenzyme q10-containing composition and method for producing the same |
| 12/27/2007 | WO2007148787A1 Process for production of a polymorph of 2-(3-cyano-4- isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid |
| 12/27/2007 | WO2007148786A1 Stabilized solid preparation |
| 12/27/2007 | WO2007148780A1 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as hiv integrase inhibitor |
| 12/27/2007 | WO2007148775A1 Chain amine compound |
| 12/27/2007 | WO2007148774A1 Cyclic amine compound |
| 12/27/2007 | WO2007148772A1 Sugar-coated reparation of macrolide antibiotic |
| 12/27/2007 | WO2007148752A1 Infusion preparation for dialysis patient |
| 12/27/2007 | WO2007148744A1 Prophylactic or therapeutic agent for corneal/conjunctival disorder comprising fumaric acid derivative as active ingredient |
| 12/27/2007 | WO2007148714A1 Implant using rifamycin derivative |
| 12/27/2007 | WO2007148713A1 Drug for treating vascular disease or drug for controlling cell proliferation comprising rifamycin derivative as the active ingredient |